sPLA2 (Type III) (CAS 9001-84-7)
QUICK LINKS
sPLA2 (Type III) is an enzyme that belongs to the phospholipase A2 (PLA2) family. It is involved in the hydrolysis of the sn-2 position of phospholipids, resulting in the release of free fatty acids and lysophospholipids. This enzyme distributed in various tissues and also in mammalian pancreatic juice, snake venom, and bee venom. sPLA2 (Type III) plays a role in lipid metabolism and the inflammatory response. It is involved in the regulation of cell signaling and membrane remodeling. This enzyme has been studied for its role in various physiological and pathological processes, including inflammation, atherosclerosis, and cancer. sPLA2 (Type III) exhibis calcium-dependent activity and is sensitive to inhibition by certain small molecules. Its structure and function contributes to a better understanding of lipid metabolism and inflammatory pathways.
sPLA2 (Type III) (CAS 9001-84-7) References
- Petrosaspongiolide M reduces morphine withdrawal in vitro. | Capasso, A., et al. 2003. Life Sci. 73: 611-6. PMID: 12770615
- Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A(2). | Murakami, M., et al. 2005. J Biol Chem. 280: 24987-98. PMID: 15863501
- Secretory phospholipase A2 type III enhances alpha-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity. | Yang, X., et al. 2010. J Lipid Res. 51: 957-66. PMID: 19805624
- Analysis of artificially oxidized cardiolipins and monolyso-cardiolipins via liquid chromatography/high-resolution mass spectrometry and Kendrick mass defect plots after hydrophilic interaction liquid chromatography based sample preparation. | Helmer, PO., et al. 2020. Rapid Commun Mass Spectrom. 34: e8566. PMID: 31469924
- Mast Cell-Specific Deletion of Group III Secreted Phospholipase A2 Impairs Mast Cell Maturation and Functions. | Taketomi, Y., et al. 2021. Cells. 10: PMID: 34359862
- Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. | Arbibe, L., et al. 1998. J Clin Invest. 102: 1152-60. PMID: 9739049
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
sPLA2 (Type III), 1 mg | sc-205512 | 1 mg | $55.00 | |||
sPLA2 (Type III), 5 mg | sc-205512A | 5 mg | $265.00 | |||
sPLA2 (Type III), 25 mg | sc-205512B | 25 mg | $460.00 | |||
sPLA2 (Type III), 100 mg | sc-205512C | 100 mg | $1845.00 | |||
sPLA2 (Type III), 250 mg | sc-205512D | 250 mg | $4030.00 | |||
sPLA2 (Type III), 500 mg | sc-205512E | 500 mg | $7300.00 | |||
sPLA2 (Type III), 1 g | sc-205512F | 1 g | $12240.00 |